Abbott Laboratories NYSE: ABT reported third-quarter sales growth of 7% and adjusted earnings-per-share growth of 9%, while announcing plans to separate its nutrition business into an independent publicly traded company through a tax-free distribution to shareholders.Chairman and Chief Executive Officer Robert Ford said the planned separation follows a strategic review and is intended to give both businesses greater operational focus. The company expects to complete the transaction by the end of next year, ...